Catalyst Wire Dossier Catalyst Wire Dossier

Orialpha

BD-C · Oriplantee Company Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Orialpha, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers] [Phase 1]

See pricing